ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

Avoiding the Hippocampus During Whole-Brain Radiotherapy Can Preserve Memory Function

September 27, 2013